Demonstrating an Analyses of Clinical Data Evaluating Psychotropic Medication Reductions and the ACHIEVE! Program in Adolescents with Severe Problem Behavior.
Adolescents with intellectual and developmental disability
Polypharmacy
Psychopharmacological interventions
Severe problem behavior
The ACHIEVE! program
Journal
Perspectives on behavior science
ISSN: 2520-8977
Titre abrégé: Perspect Behav Sci
Pays: Switzerland
ID NLM: 101743058
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
accepted:
15
12
2020
entrez:
28
3
2022
pubmed:
29
3
2022
medline:
29
3
2022
Statut:
epublish
Résumé
Researchers report increasing trends in psychotropic medication use to treat problem behavior in individuals with intellectual and developmental disability, despite some controversy regarding its application and treatment efficacy. A substantial evidence base exists supporting behavioral intervention efficacy, however research evaluating separate and combined intervention (i.e., concurrent application of behavioral and psychopharmacological interventions) effects remains scarce. This article demonstrates how a series of analyses on clinical data collected during treatment (i.e., four case studies) may be used to retrospectively explore separate and combined intervention effects on severe problem behavior. First, we calculated individual effect sizes and corresponding confidence intervals. The results indicated larger problem behavior decreases may have coincided more often with behavioral intervention adjustments compared to medication adjustments. Second, a conditional rates analysis indicated surges in problem behavior did not reliably coincide with medication reductions. Spearman correlation analyses indicated a negative relationship between behavioral intervention phase progress and weekly episodes of problem behavior compared to a positive relationship between total medication dosage and weekly episodes of problem behavior. However, a nonparametric partial correlation analyses indicated individualized, complex relationships may exist among total medication dosage, behavioral intervention, and weekly episodes of problem behavior. We discuss potential clinical implications and encourage behavioral researchers and practitioners to consider applying creative analytic strategies to evaluate separate and combined intervention effects on problem behavior to further explore this extremely understudied topic. The online version contains supplementary material available at 10.1007/s40614-020-00279-3.
Identifiants
pubmed: 35342870
doi: 10.1007/s40614-020-00279-3
pii: 279
pmc: PMC8894527
doi:
Types de publication
Journal Article
Langues
eng
Pagination
125-151Informations de copyright
© Association for Behavior Analysis International 2021.
Déclaration de conflit d'intérêts
Conflict of InterestsWe have no known conflict of interests to disclose.
Références
Can J Psychiatry. 2018 Jun;63(6):361-369
pubmed: 28830241
J Intellect Disabil Res. 2017 Oct;61(10):899-908
pubmed: 28560761
J Speech Lang Hear Res. 2015 Oct;58(5):1464-81
pubmed: 26184118
Behav Anal Pract. 2018 Feb 23;11(4):350-357
pubmed: 30538908
J Appl Behav Anal. 1978 Summer;11(2):203-14
pubmed: 16795590
J Pediatr Psychol. 2009 Oct;34(9):917-28
pubmed: 19223279
Dtsch Arztebl Int. 2009 May;106(19):335-9
pubmed: 19547734
J Appl Behav Anal. 2016 Mar;49(1):85-104
pubmed: 26391410
Int J Dev Disabil. 2016;62(3):200-211
pubmed: 27429750
J Appl Behav Anal. 2006 Summer;39(2):189-202
pubmed: 16813040
J Appl Behav Anal. 2004 Winter;37(4):431-44
pubmed: 15669403
Am J Ment Retard. 2005 May;110(3):164-70
pubmed: 15804192
J Neurosci. 2001 Jan 15;21(2):RC121
pubmed: 11160455
J Appl Behav Anal. 2016 Jun;49(2):265-85
pubmed: 27037669
Pediatrics. 2013 Nov;132(5):833-40
pubmed: 24144704
J Dev Phys Disabil. 2017 Dec;29(6):969-982
pubmed: 29398883
Res Dev Disabil. 1999 Jan-Feb;20(1):1-21
pubmed: 9987807
J Appl Behav Anal. 2020 Apr;53(2):596-619
pubmed: 32125716
Curr Opin Psychiatry. 2016 Mar;29(2):103-25
pubmed: 26779860
Int J Neuropsychopharmacol. 2014 Mar;17(3):371-81
pubmed: 24103254
Behav Modif. 2007 Nov;31(6):825-46
pubmed: 17932238
J Appl Behav Anal. 2013 Summer;46(2):498-506
pubmed: 24114163
Eur J Pharmacol. 2018 Jun 15;829:129-140
pubmed: 29627310
J Autism Dev Disord. 2005 Feb;35(1):3-13
pubmed: 15796117
J Child Adolesc Psychopharmacol. 2016 May;26(4):314-26
pubmed: 26859445
PLoS One. 2018 Nov 29;13(11):e0208047
pubmed: 30496322
J Appl Behav Anal. 1992 Fall;25(3):713-21
pubmed: 1429322
J Appl Behav Anal. 2009 Summer;42(2):413-23
pubmed: 19949534
J Psychiatry Neurosci. 2000 May;25(3):241-54
pubmed: 10863884
Am J Ment Retard. 2004 Jul;109(4):310-21
pubmed: 15176916
J Appl Behav Anal. 2013 Spring;46(1):1-21
pubmed: 24114081
J Intellect Disabil Res. 2015 Jan;59(1):11-25
pubmed: 24450426
Prim Care Companion J Clin Psychiatry. 1999 Apr;1(2):50-51
pubmed: 15014696
Res Dev Disabil. 2009 May-Jun;30(3):572-86
pubmed: 18845418
Isr J Psychiatry Relat Sci. 2006;43(4):265-74
pubmed: 17338446